Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Clinical and Molecular Allergy : CMA|May 14, 2019
Immunosuppressive therapy with rituximab in common variable immunodeficiencyAntonio Pecoraro, Ludovica Crescenzi, Maria Rosaria Galdiero, et al.
Journal of Clinical Medicine|April 30, 2021
Episodic Angioedema with Hypereosinophilia (Gleich's Syndrome): A Case Report and Extensive Review of the LiteratureIlaria Mormile, Angelica Petraroli, Stefania Loffredo, et al.
Allergy|August 11, 2022
Biologics and airway remodeling in severe asthmaGilda Varricchi, Sebastian Ferri, Jack Pepys, et al.
European Journal of Immunology|April 1, 2015
IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytesFrancesco Borriello, Michele Longo, Rosa Spinelli, et al.
Frontiers in Immunology|August 27, 2024
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cellsRemo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Clinical Drug Investigation|September 8, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in ItalyRaffaella Viti, Andrea Marcellusi, Alessandro Capone, et al.
Therapeutic Advances in Respiratory Disease|April 29, 2021
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life studyAikaterini Detoraki, Eugenio Tremante, Maria D'Amato, et al.
Respiratory Research|June 24, 2021
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case seriesAikaterini Detoraki, Eugenio Tremante, Remo Poto, et al.
Frontiers in Immunology|November 21, 2018
Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable ImmunodeficiencyFederica Pulvirenti, Antonio Pecoraro, Francesco Cinetto, et al.
Clinical Drug Investigation|February 13, 2015
Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter studyAlessandra Vultaggio, Chiara Azzari, Cinzia Milito, et al.
Pageof 14